Dronabinol (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Dronabinol drug offered from Mylan Pharmaceuticals Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Dronabinol |
SUBSTANCE NAME: | DRONABINOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, LIQUID FILLED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-11-01 |
END MARKETING DATE: | 0000-00-00 |
Dronabinol HUMAN PRESCRIPTION DRUG Details:
Item Description | Dronabinol from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2011-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-8170_d3ae47c9-893c-41b8-b2a0-38f5fb3c1a31 |
PRODUCT NDC: | 0378-8170 |
APPLICATION NUMBER: | ANDA078501 |
Other DRONABINOL Pharmaceutical Manufacturers / Labelers: